Australia's most trusted
source of pharma news
Thursday, 30 July 2026
Posted 29 July 2026 PM
Re-engineering Health Technology Assessment (HTA) to improve access to treatments will be the centre of discussions at the Private Cancer Physicians of Australia (PCPA) Cancer Summit next month.
| - |
The not-for-profit organisation whose membership spans medical and radiation oncologists, haematologists, consultants and advanced trainees, has advocated for cancer patients, clinicians and highly-quality, equitable care across Australia’s mixed health system since 2007.

Please click the button to indicate that the printout of this article is for your personal use only and not for any type of redistribution.
Redistribution of the whole or part of Pharma in Focus by any means is a breach of copyright law.